Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response

被引：0
|
作者：
D'Anna, Stefano [1 ]
Salpini, Romina [1 ]
Degasperi, Elisabetta [2 ]
Duca, Leonardo [1 ,3 ]
Anolli, Maria Paola [2 ]
Piermatteo, Lorenzo [1 ]
Sambarino, Dana [2 ]
Borghi, Marta [2 ]
Facchetti, Floriana [2 ]
Silberstein, Francesca Ceccherini [1 ]
Perbellini, Riccardo [2 ]
Svicher, Valentina [1 ,3 ]
Lampertico, Pietro [2 ,4 ]
机构：
[1] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[3] Univ Roma Tor Vergata, Dept Biol, Rome, Italy
[4] CRC AM & A Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-159
引用
收藏
页码：S1142 / S1142
页数：1
相关论文
共 50 条
  • [31] BULEVIRTIDE IMPROVES HEALTH RELATED QUALITY LIFE MEASURED BY EQ-5D VAS IN PATIENTS WITH CHRONIC HEPATITIS DELTA: AN EXPLORATORY ANALYSIS OF A PHASE 3 TRIAL AT 48 WEEKS
    Buti, Maria
    Wedemeyer, Heiner
    Aleman, Soo
    Chulanov, Vladimir
    Morozov, Viacheslav
    Sagalova, Olga
    Stepanova, Tatyana
    Gish, Robert G.
    Lloyd, Andrew
    Kaushik, Ankita Modi
    Suri, Vithika
    Manuilov, Dmitry
    Osinusi, Anu O.
    Flaherty, John F.
    Pandey, Shubhram
    Singh, Barinder
    Lampertico, Pietro
    HEPATOLOGY, 2022, 76 : S224 - S225
  • [32] CHARACTERIZATION OF HBSAG KINETICS AND HBSAG SEROCONVERSION IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
    Marcellin, Patrick
    Heathcote, E. Jenny
    Buti, Maria
    Krastev, Zahary
    Jacobson, Ira M.
    de Man, Robert A.
    Dusheiko, Geoffrey M.
    Zeuzem, Stefan
    Barnes, Chris N.
    Lou, Lillian
    HEPATOLOGY, 2011, 54 : 1036A - 1036A
  • [33] PREDICTIVE VALUE OF HBSAG TITER FOR EARLY VIROLOGICAL RESPONSE TO ENTECAVIR IN CHRONIC HEPATITIS B
    Song, Joonchang
    Kim, Jongyeob
    Kim, Yeomyung
    Jeong, Sookhyang
    Kim, Jinwook
    HEPATOLOGY, 2010, 52 (04) : 529A - 529A
  • [34] Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients
    Zulian, Verdiana
    Salichos, Leonidas
    Taibi, Chiara
    Pauciullo, Silvia
    Dong, Levi
    D'Offizi, Gianpiero
    Biliotti, Elisa
    Rianda, Alessia
    Federici, Luigi
    Bibbo, Angela
    De Sanctis, Martina
    Mcphee, Fiona
    Garbuglia, Anna Rosa
    BIOMEDICINES, 2025, 13 (02)
  • [35] NO DETECTABLE RESISTANCE TO BULEVIRTIDE MONOTHERAPY THROUGH 96 WEEKS TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS D
    Aleman, Soo
    Liu, Yang
    Xu, Simin
    Chang, Silvia
    Martin, Ross
    Aeschbacher, Thomas
    May, Lindsey
    Manhas, Savrina
    Han, Dong
    Yazdi, Tahmineh
    Martinez, Clarissa
    Ho, Pui Yan
    Richards, Christopher
    Marceau, Caleb
    Manuilov, Dmitry
    Flaherty, John F.
    Maiorova, Evguenia
    Mo, Hongmei
    Wedemeyer, Heiner
    Lampertico, Pietro
    HEPATOLOGY, 2023, 78 : S398 - S399
  • [36] Correlation Between Serum Entecavir Concentration and Virological Response in Patients with Chronic Type B Hepatitis
    Wu, Zhengjie
    Gong, Yiwen
    Peng, Jun
    Zhang, Xiao
    Tang, Lingling
    MEDICAL SCIENCE MONITOR, 2019, 25 : 6998 - 7004
  • [37] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN
    Paci, M.
    Lorefice, E.
    Gianni, E.
    Renzo, S.
    Capanni, M.
    Forte, P.
    Milani, S.
    Surrenti, C.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S113 - S113
  • [38] Immunological biomarkers of virological response in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Menezes, E.
    Reis, J.
    Cardoso, L.
    Teixeira Carvalho, A.
    Filho, A. M. O.
    Teixeira, R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1269 - 1269
  • [39] No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
    Hollnberger, Julius
    Liu, Yang
    Xu, Simin
    Chang, Silvia
    Martin, Ross
    Manhas, Savrina
    Aeschbacher, Thomas
    Han, Bin
    Yazdi, Tahmineh
    May, Lindsey
    Han, Dong
    Shornikov, Alex
    Flaherty, John
    Manuilov, Dmitry
    Suri, Vithika
    Asselah, Tarik
    Lampertico, Pietro
    Wedemeyer, Heiner
    Aleman, Soo
    Richards, Christopher
    Mateo, Roberto
    Maiorova, Evguenia
    Cihlar, Tomas
    Mo, Hongmei
    Urban, Stephan
    JOURNAL OF HEPATOLOGY, 2023, 79 (03) : 657 - 665
  • [40] 48 WEEKS, PROFOUND SUPPRESSION CORRELATES WITH GREATER SUSTAINED RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR
    Lee, Hyun Woong
    Cha, Bong Ki
    Yang, Suh Yoon
    Kim, Hyung J.
    HEPATOLOGY, 2011, 54 : 1029A - 1029A
12345